These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 28554751)

  • 1. Correlations of Foxo3 and Foxo4 expressions with clinicopathological features and prognosis of bladder cancer.
    Wang Y; Kang XL; Zeng FC; Xu CJ; Zhou JQ; Luo DN
    Pathol Res Pract; 2017 Jul; 213(7):766-772. PubMed ID: 28554751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic and prognostic significance of p21 (Cip1/Waf1) expression in bladder cancer.
    Tang K; Wang C; Chen Z; Xu H; Ye Z
    Int J Clin Exp Pathol; 2015; 8(5):4999-5007. PubMed ID: 26191193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FOXO3a expression is associated with lymph node metastasis and poor disease-free survival in triple-negative breast cancer.
    Rehman A; Kim Y; Kim H; Sim J; Ahn H; Chung MS; Shin SJ; Jang K
    J Clin Pathol; 2018 Sep; 71(9):806-813. PubMed ID: 29588373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinicopathological significance of forkhead box P1 and forkhead box O3a in pancreatic ductal adenocarcinomas.
    Luo X; Yang Z; Liu X; Liu Z; Miao X; Li D; Zou Q; Yuan Y
    Tumour Biol; 2017 May; 39(5):1010428317699129. PubMed ID: 28466777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXO4 and FOXD3 are predictive of prognosis in gastric carcinoma patients.
    Li J; Jiang Z; Han F; Liu S; Yuan X; Tong J
    Oncotarget; 2016 May; 7(18):25585-92. PubMed ID: 27027443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-cycle markers do not improve discrimination of EORTC and CUETO risk models in predicting recurrence and progression of non-muscle-invasive high-grade bladder cancer.
    Passoni N; Gayed B; Kapur P; Sagalowsky AI; Shariat SF; Lotan Y
    Urol Oncol; 2016 Nov; 34(11):485.e7-485.e14. PubMed ID: 27637323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue factor expression correlates with disease-specific survival in patients with node-negative muscle-invasive bladder cancer.
    Patry G; Hovington H; Larue H; Harel F; Fradet Y; Lacombe L
    Int J Cancer; 2008 Apr; 122(7):1592-7. PubMed ID: 18058798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histological and immunohistochemical markers for progression prediction in transurethrally resected high-grade non-muscle invasive bladder cancer.
    Kim K; Cho YM; Park BH; Lee JL; Ro JY; Go H; Shim JW
    Int J Clin Exp Pathol; 2015; 8(1):743-50. PubMed ID: 25755769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External validation of FXYD3 and KRT20 as predictive biomarkers for the presence of micrometastasis in muscle invasive bladder cancer lymph nodes.
    Ramírez-Backhaus M; Fernández-Serra A; Rubio-Briones J; Cruz Garcia P; Calatrava A; Garcia Casado Z; Casanova Salas I; Rubio L; Solsona E; López-Guerrero JA
    Actas Urol Esp; 2015 Oct; 39(8):473-81. PubMed ID: 25920992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of long noncoding RNA NORAD indicates a poor prognosis and promotes clinical progression and metastasis in bladder cancer.
    Li Q; Li C; Chen J; Liu P; Cui Y; Zhou X; Li H; Zu X
    Urol Oncol; 2018 Jun; 36(6):310.e15-310.e22. PubMed ID: 29605462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and function analysis of indoleamine 2 and 3-dioxygenase in bladder urothelial carcinoma.
    Yang C; Zhou Y; Zhang L; Jin C; Li M; Ye L
    Int J Clin Exp Pathol; 2015; 8(2):1768-75. PubMed ID: 25973066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bromodomain 4 protein is a predictor of survival for urothelial carcinoma of bladder.
    Yan Y; Yang FQ; Zhang HM; Li J; Li W; Wang GC; Che JP; Zheng JH; Liu M
    Int J Clin Exp Pathol; 2014; 7(7):4231-8. PubMed ID: 25120803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of protocadherin 8 (PCDH8) promoter methylation in non-muscle invasive bladder cancer.
    Lin YL; Wang YL; Ma JG; Li WP
    J Exp Clin Cancer Res; 2014 Aug; 33(1):68. PubMed ID: 25927589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Expression of Long Noncoding RNA MALAT1 Indicates a Poor Prognosis and Promotes Clinical Progression and Metastasis in Bladder Cancer.
    Li C; Cui Y; Liu LF; Ren WB; Li QQ; Zhou X; Li YL; Li Y; Bai XY; Zu XB
    Clin Genitourin Cancer; 2017 Oct; 15(5):570-576. PubMed ID: 28648755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective evaluation of a molecular marker panel for prediction of recurrence and cancer-specific survival after radical cystectomy.
    Lotan Y; Bagrodia A; Passoni N; Rachakonda V; Kapur P; Arriaga Y; Bolenz C; Margulis V; Raj GV; Sagalowsky AI; Shariat SF
    Eur Urol; 2013 Sep; 64(3):465-71. PubMed ID: 23571005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High levels of γ-glutamyl hydrolase (GGH) are associated with poor prognosis and unfavorable clinical outcomes in invasive breast cancer.
    Shubbar E; Helou K; Kovács A; Nemes S; Hajizadeh S; Enerbäck C; Einbeigi Z
    BMC Cancer; 2013 Feb; 13():47. PubMed ID: 23374458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of TNFAIP8 is associated with tumor aggressiveness and poor prognosis in patients with invasive ductal breast carcinoma.
    Xiao M; Xu Q; Lou C; Qin Y; Ning X; Liu T; Zhao X; Jia S; Huang Y
    Hum Pathol; 2017 Apr; 62():40-49. PubMed ID: 28087477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
    Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
    J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-199a-3p and miR-214-3p improve the overall survival prediction of muscle-invasive bladder cancer patients after radical cystectomy.
    Ecke TH; Stier K; Weickmann S; Zhao Z; Buckendahl L; Stephan C; Kilic E; Jung K
    Cancer Med; 2017 Oct; 6(10):2252-2262. PubMed ID: 28879675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and localisation of FoxO3 and FoxO4 in human placenta and fetal membranes.
    Lappas M; Lim R; Riley C; Menon R; Permezel M
    Placenta; 2010 Dec; 31(12):1043-50. PubMed ID: 20934750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.